RenovoRx to present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
RNXT•RenovoRx said CEO Shaun Bagai and CFO Mark Voll will present at the forum on November 11, 2026, at 2 p.m. ET in New York and review third-quarter results, commercial execution and physician adoption of its platform.
1. Forum presentation
RenovoRx said CEO Shaun Bagai and CFO Mark Voll will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026, at 2 p.m. ET in New York. Management will review third-quarter 2026 financial results, commercial execution and physician adoption of its targeted drug-delivery platform.




